Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02367404
What this trial is testing

Prospective RCT on Post Prostatectomy Urine Leak

Who this might be right for
Prostate CancerUrinary Incontinence
Institut Mutualiste Montsouris 240
Testing effectiveness (Phase 2)WithdrawnNCT01530984
What this trial is testing

Ipilimumab and GMCSF Immunotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Lawrence Fong
Testing effectiveness (Phase 2)Study completedNCT01558219
What this trial is testing

Second-line Chemotherapy in Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Tampere University Hospital 60
Not applicableLooking for participantsNCT05767307
What this trial is testing

Danish Prostate Cancer Consortium Study-1

Who this might be right for
Prostate Cancer
Aarhus University Hospital 2,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT04104893
What this trial is testing

CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
VA Office of Research and Development 40
Testing effectiveness (Phase 2)Study completedNCT00345293
What this trial is testing

Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer

Who this might be right for
Prostate Cancer
Rockefeller University 13
Testing effectiveness (Phase 2)Study completedNCT03434158
What this trial is testing

Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL)

Who this might be right for
Prostate Cancer Metastatic
Spanish Oncology Genito-Urinary Group 16
Very early researchLooking for participantsNCT03861676
What this trial is testing

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07608718
What this trial is testing

Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Pedro Barata, MD, MSc 19
Not applicableStudy completedNCT06168890
What this trial is testing

Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure.

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 195
Not applicableStudy completedNCT00777452
What this trial is testing

A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Samsung Medical Center 93
Testing effectiveness (Phase 2)Study completedNCT02431676
What this trial is testing

Survivorship Promotion In Reducing IGF-1 Trial

Who this might be right for
Breast CancerProstate CancerLung Cancer+8 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 121
Early research (Phase 1)Study completedNCT00790374
What this trial is testing

BN83495 in Prostate Cancer

Who this might be right for
Prostate Cancer
Ipsen 17
Not applicableTemporarily pausedNCT07146113
What this trial is testing

Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

Who this might be right for
Prostate Cancer
AstraZeneca 400
Testing effectiveness (Phase 2)Study completedNCT03311555
What this trial is testing

A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)

Who this might be right for
Prostate Cancer
Andrew J. Armstrong, MD 39
Testing effectiveness (Phase 2)Study completedNCT04207255
What this trial is testing

Addition of Opaganib to Androgen Antagonists in Patients With mCRPC

Who this might be right for
Prostate Cancer
Medical University of South Carolina 69
Not applicableActive Not RecruitingNCT01607008
What this trial is testing

MRI for Assessing Prostate Cancer Response

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Testing effectiveness (Phase 2)Looking for participantsNCT03753243
What this trial is testing

Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Mark Garzotto, MD 32
Not applicableStudy completedNCT06128525
What this trial is testing

Prostate Resection After Microwave Ablation (PRAMA)

Who this might be right for
Prostate Carcinoma
University of Southern California 1
Testing effectiveness (Phase 2)Study completedNCT01934790
What this trial is testing

Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases

Who this might be right for
Prostatic Neoplasms
Bayer 45
Next Page